MedTrace Logo

Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity

NCT02274480 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2020-09-04

No results posted yet for this study

Summary

The goal of this study is to see if a special type of heart scan called a diffusion weighted magnetic resonance imaging (DW-MRI) that uses extra measurements, can be used to find early signs of heart damage from chemotherapy.

Conditions

  • Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients

Interventions

DEVICE

cardiac MRI with DWI

Sponsors & Collaborators

Principal Investigators

  • Andrew Plodkowski, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-22
Primary Completion
2020-09-02
Completion
2020-09-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02274480 on ClinicalTrials.gov